Medical/Pharmaceuticals
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment to its strategic collaboration agreement with R...
2025-10-31 17:38
1293
Xinhua Silk Road: Chinese biz leaders hold talks to explore cultural inheritance, innovation
BEIJING, Oct. 31, 2025 /PRNewswire/ -- On Tuesday, an in-depth talk between board chairmen of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang) and Kweichow Moutai Group highlighted joint effort to promote inheritance and innovation of traditional Chinese culture. After discussi...
2025-10-31 16:15
900
Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by "Championing the Missions that Matter™"
TAMPA, Fla., Oct. 31, 2025 /PRNewswire/ -- Catalent, Inc., a leading global contract development and manufacturing organization, today unveiled its new corporate brand, marking a strategic evolution that underscores the company's commitment to delivering unparalleled customer service and its focu...
2025-10-31 08:30
1083
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries
* NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' strong clinical and commercialization expertise inGreater China and other Asian markets * Nov...
2025-10-30 16:15
1106
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
* Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 inGreater China, Singapore, South Korea, and certain Southeast Asian countries. * Under the assigned exclusive license, Everest Medicines will make an upfront payment ofUS$7 million (equivalen...
2025-10-30 11:05
1381
LOTTE BIOLOGICS and SK pharmteco Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities
* Two global CDMO leaders have joined forces to strengthen their presence in the rapidly growing antibody-drug conjugate (ADC) market. * The collaboration will deliver integrated, one-stop CDMO services spanning antibody drug substance, linker–payload production, and bioconjugation, supported...
2025-10-30 09:15
1273
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announcedthe initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infection. Building on ArkBio's previous experi...
2025-10-30 09:00
1273
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately15 days, 3-fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91% greater relative body weight reduction compared t...
2025-10-30 08:10
1252
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications - BASEL, Switzerland, Oct. 29, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable ingredients, and P...
2025-10-29 23:21
1442
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
* New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwide * Strategy centers on broadening access to global capital and innovation through a plannedHong Kong initial public offering (IPO), and holding...
2025-10-29 23:15
2722
Suvoda launches unified patient app to reduce logistical challenges for clinical trial participants
CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ -- Suvoda
2025-10-29 21:15
1159
Study Finds ELISAs in Milk Samples Less Reliable for Johne's Disease Detection -- $198M in Dairy Losses Underscore Need for More Accurate Milk Testing
Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance and profitability CARLSBAD, Calif., Oct. 29, 2025 /PRNewswire/ -- Pictor Holdings Inc. today announced new peer-reviewed dat...
2025-10-29 21:00
1168
ICHORtec and Johns Hopkins University Expand Collaboration to Enhance CRISPR Gene Editing Specificity Using Quantum FMB® Technology
BERLIN and BALTIMORE, Oct. 29, 2025 /PRNewswire/ -- ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School of Medicine. This partnership, aligned with the...
2025-10-29 21:00
1310
"World Hair Transplant Repair Day" Taking Place on 11/11 Shines Light on Proliferation, Dangers of Black-Market Hair Transplant Clinics Worldwide
ISHRS Hosts Live Surgery Workshop in Bucharest, Romania, November 7-9, 2025,
focusing on hair repair
CHICAGO, Oct. 29, 2025 /PRNewswire/ -- According to a recent member survey
2025-10-29 20:11
1104
/C O R R E C T I O N -- GSK/
In the news release, Five social service agencies join Singapore's shingles awareness movement, issued29-Oct-2025 by GSK over PR Newswire, we are advised by the company that the one of the community partner's name, should read "Lions Befrienders" rather than "Lion Befrienders" as originally issue...
2025-10-29 16:59
1157
Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University
TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics and a vaccine for tuberculosis (TB), neglected tropical diseases...
2025-10-29 10:00
848
A Breakthrough in Color Measurement Is Coming: The HunterLab Agera L2
RESTON, Va., Oct. 29, 2025 /PRNewswire/ -- A breakthrough in color measurement
is on the horizon. This November,HunterLab
2025-10-29 08:00
1043
NABR: New review of long-tailed macaque population recommends two steps for accurate reassessment of long-tailed macaque global population
WASHINGTON, Oct. 29, 2025 /PRNewswire/ -- A recent article published in the
American Journal of Primatology criticizes work relied upon by the
International Union for Conservation of Nature (IUCN) in its latest
determination concerning long-tailed macaque monkeys (Macaca fascicularis).
2025-10-29 01:03
1186
SI GROUP OPENS NEW INNOVATION CENTER
State-of-the-art facility expands company's global research and development
capabilities
THE WOODLANDS, Texas, Oct. 28, 2025 /PRNewswire/ -- SI Group
2025-10-28 20:30
828
Sisram Medical Delivers Strong Third-Quarter 2025 Performance with Robust Momentum Across Key Markets and Core Businesses
HONG KONG, Oct. 28, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today ann...
2025-10-28 20:29
1942
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 277 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 268 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 258 media titles]
2025-12-29 14:27Most Read
GreenTree Hospitality Group Ltd. Reports Third Quarter of 2025 Financial Results
2025-12-23 22:30
3665
Highway Holdings Plans to Acquire 51% of Regent-Feinbau Adermann GmbH
2025-12-23 20:00
3478
